About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Boston | 459 Studies

Clinical Trials Prostate CancerBoston

Prostate Cancer Clinical Trials in Boston

Find 459 clinical trials for prostate cancer near Boston, Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 301-320 of 459 trials

UnknownIncreasing Access to Definitive Treatment for Prostate CancerInvestigators will address the overarching challenge of advancing health equity and reducing disparities in prostate cancer by informing efforts to reduce travel burden in…NCT06034431·Boston, Massachusetts CompletedIncorporating MR Imaging Into Prostate Radiotherapy Treatment PlanningThis research study is evaluating whether a standard prostate MRI examination can improve radiation therapy planning for prostate cancer.NCT02470910·Boston, Massachusetts RecruitingThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsThis is a phase 1 dose escalation trial of ZM008, an anti-LLT1 antibody as a single agent followed by combination with Toripalimab in patients with advanced solid tumors who have…NCT06451497·Boston, Massachusetts and 2 others RecruitingEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsThe objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and…NCT05983432·Beverly Hills, California and 36 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of LY4257496 in Participants With Cancer (OMNIRAY)The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relevant standard of care (SOC) combination therapy in…NCT07114601·Duarte, California and 32 others

SuspendedA Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7NPX267 is an antibody drug targeting the inhibitory receptor for B7-H7 (HHLA2) which may control evasion of the immune response in tumors.NCT05958199·Baltimore, Maryland and 6 others

CompletedPhase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerThe VIABLE study sought to confirm the hypothesis that the combination of docetaxel with DCVAC/PCa followed by a maintenance therapy with DCVAC/PCa would improve overall survival…NCT02111577·Mobile, Alabama and 176 others

RecruitingA Study in Patients With Metastatic Castration-Resistant Prostate CancerThe goal of this clinical trial is to find out if FX-111 is safe enough to permit further studies in adult male participants with metastatic castration-resistant prostate cancer…NCT07719361·Los Angeles, California and 9 others

CompletedMRI-guided Bone Marrow Biopsies of Prostate Cancer PatientsThe purpose of this study is to target lesions of the prostate in the bone and to biopsy these lesions using MRI to identify the areas.NCT00165386·Boston, Massachusetts

Completed131-I-TM-601 Study in Adults With Solid TumorsThis study is designed to evaluate the ability of intravenously (IV)administered 131-I-labeled TM-601 (chlorotoxin) to provide tumor-specific localization(via radiographic…NCT00379132·Birmingham, Alabama and 5 others

RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate CancerThe objective of this study is to see if providing an appropriate therapy based on the genomic testing of prostate tumour tissue will result in an improved clinical response.NCT04812366·Sacramento, California and 8 others

CompletedExercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation TherapyThis research study is evaluating the impact and feasibility of a 12-week brisk walking and moderate strength training exercise intervention including a virtual component in men…NCT03070145·Boston, Massachusetts

CompletedSurgery in Treating Patients With Prostate CancerRATIONALE: Prostatectomy may be an effective treatment for prostate cancer that has not responded to radiation therapy.NCT00002938·Anniston, Alabama and 60 others

Active not recruitingM6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate CancerThis phase II trial studies how well berzosertib (M6620) and carboplatin with or without docetaxel works in treating patients with castration-resistant prostate cancer that has…NCT03517969·Duarte, California and 22 others

Active not recruitingNivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed TumorsThis research study is studying a combination of hormonal therapy, chemotherapy, and immunotherapy as a possible treatment for metastatic hormone-sensitive prostate cancer.NCT04126070·La Jolla, California and 5 others

Active not recruitingProton Therapy vs. IMRT for Low or Intermediate Risk Prostate CancerWe are studying whether men being treated for prostate cancer have the same amount of side effects from either one of two different external radiation treatments: IMRT or PBT.NCT01617161·Jacksonville, Florida and 12 others

CompletedRadiation Therapy in Treating Patients With Stage II Prostate CancerRATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving hypofractionated…NCT00331773·Phoenix, Arizona and 295 others

CompletedRidaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)The purpose of this study is to assess the antitumor activity of weekly ridaforolimus study treatment in participants with taxane-resistant AIPC.NCT00110188·Los Angeles, California and 3 others

RecruitingProstate Cancer Genetic Risk Evaluation and Screening StudyThis study aims to define the natural history of men at high genetic risk for prostate cancer on the basis of specific germline genetic mutations, family history, or Black/African…NCT05129605·Boston, Massachusetts

RecruitingExercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE TrialThe purpose of this study is to determine whether a 12-week, home-based, virtually supervised exercise program will slow cancer progression of prostate cancer among men with…NCT05918263·Boston, Massachusetts and 3 others

PreviousPage 16 of 23Next

Other Conditions in Boston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma